NCT Number: NCT00004670
Phase II Study of Pallidotomy for Parkinson Disease
OBJECTIVES:
I. Evaluate the safety and efficacy of pallidotomy immediately following 3 preoperative assessments vs. delayed pallidotomy following 6 months of standard medical therapy in patients with Parkinson disease.
Looking for future studies?
Notify MeKey information
Conditions
Age range
30 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
About this study
PROTOCOL OUTLINE: This is a randomized study. One group of patients undergoes the surgical procedure pallidotomy, a precise lesioning of brain cells in the globus pallidus.
The other group receives standard medical care for 6 months followed by a pallidotomy.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
Idiopathic Parkinson disease Hoehn and Yahr stage III or worse during "off" periods
Responsive to levodopa by history or exam Sub-optimal clinical response to maximal medication Medication optimized for at least 4 weeks prior to entry
No atypical or secondary disease, e.g.:
- No history of cerebrovascular accident
- No cerebellar involvement
- No severe brain atrophy on magnetic resonance imaging
No Mattis Dementia Rating Scale score less than 116
No dementia meeting Diagnostic and Statistical Manual of Mental Disorders-IV criteria
No Hamilton Depression Rating Scale score greater than 10
No Hamilton Anxiety Scale score greater than 14
--Patient Characteristics--
Other: No medical contraindication to surgery, e.g.:
- Diabetes
- Cardiopulmonary disease
Treatment and study plan
Sponsors and collaborators
Lead sponsor
National Center for Research Resources (NCRR)
Nih
Collaborators
- Emory University
Registry information
Important dates
- Study start
- 1994
- First posted
- Feb 25, 2000
- Registry last updated
- Jun 24, 2005
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease
NCT00004826
Basal Ganglia Diseases, Brain Diseases
View Trial DetailsRandomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients
NCT00004451
Basal Ganglia Diseases, Brain Diseases
Charlottesville, Virginia, United States
View Trial DetailsPhase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease
NCT00004387
Basal Ganglia Diseases, Brain Diseases
View Trial DetailsStudy of Axial Mobility Exercises in Parkinson Disease
NCT00004760
Basal Ganglia Diseases, Brain Diseases
View Trial Details